Related Experiment Videos
Summary
External beam radiotherapy delivered in three daily sessions showed similar normal tissue tolerance compared to standard daily fractions. This approach may offer a viable option for advanced malignant disease treatment.
Area of Science:
- Oncology
- Radiation Oncology
- Clinical Oncology
Background:
- External beam radiotherapy is a cornerstone in cancer treatment.
- Conventional fractionation involves one daily radiation session.
- Advanced malignant diseases often require innovative treatment strategies.
Purpose of the Study:
- To report early clinical experience with a novel radiotherapy fractionation schedule.
- To evaluate the feasibility and normal tissue tolerance of three-times-daily external beam radiotherapy.
Main Methods:
- Retrospective analysis of 37 patients with advanced malignant disease.
- Treatment involved external beam radiotherapy with three sessions per day.
- Focus on patients with breast and neck cancers.
Main Results:
- The study included patients with advanced breast and neck cancers.
- External beam radiotherapy was delivered using three fractions per day.
- Normal tissue tolerance was comparable to conventional daily fractionation schedules.
Conclusions:
- Three-times-daily external beam radiotherapy demonstrated similar normal tissue tolerance.
- This fractionation schedule appears feasible for advanced cancers.
- Further research is warranted to explore its efficacy and long-term outcomes.